Curis
CRIS
#10209
Rank
โ‚น1.38 B
Marketcap
โ‚น101.06
Share price
-2.63%
Change (1 day)
-62.29%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น334.12. In 2024 the company made an earnings per share (EPS) of -โ‚น640.02 an increase over its 2023 EPS that were of -โ‚น822.10.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.64%
2024-โ‚น640.02-22.15%
2023-โ‚น822.10-26.17%
2022-โ‚น1,11322.3%
2021-โ‚น910.41-25.37%
2020-โ‚น1,220-30.93%
2019-โ‚น1,766-2.02%
2018-โ‚น1,803
2016-โ‚น4,097-10%
2015-โ‚น4,552138.1%
2014-โ‚น1,91240%
2013-โ‚น1,366-25%
2012-โ‚น1,82166.67%
2011-โ‚น1,092

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น123.82-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น270.39-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.77-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น216.68-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น307.72-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,023 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น128.37-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA